Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Cash from Financing Activities (2009 - 2026)

Revvity's (RVTY) quarterly Cash from Financing Activities came in at -$23.2 million in Q3 2026, up 92.34% on a YoY basis from -$12.0 million in Q3 2025, and up 73.95% quarter-over-quarter from -$88.9 million in Q2 2026.

Analysis

Revvity (RVTY) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Cash from Financing Activities for 18 consecutive years, with -$23.2 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Cash from Financing Activities rose 92.34% year-over-year to -$23.2 million; the trailing twelve-month figure through Jul 2026 stood at -$503.4 million (up 67.16% YoY), and the FY2025 full-year result was -$857.5 million, up 23.99% from the prior year.
  • Cash from Financing Activities improved to -$23.2 million in Q3 2026 per RVTY's latest filing, from -$88.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at -$19.6 million in Q4 2023 and bottomed at -$3.7 billion in Q1 2023.
  • Historically, Cash from Financing Activities has averaged -$434.5 million across 5 years, with a median of -$170.6 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 99.48% in 2023, then sank 1041.63% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$164.9 million in 2022, then soared by 88.1% to -$19.6 million in 2023, then slumped by 883.94% to -$193.0 million in 2024, then rose by 8.64% to -$176.3 million in 2025, then soared by 86.86% to -$23.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered -$23.2 million, -$88.9 million, and -$176.3 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -1.57 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 7.27 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 471.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -129.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -23.16 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -33.21 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -27.60 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -6.20 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.02 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 149.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 -23.16 Mn
Apr 5, 2026 -88.90 Mn
Dec 28, 2025 -176.31 Mn
Sep 28, 2025 -215.07 Mn
Jun 29, 2025 -302.48 Mn
Mar 30, 2025 -163.66 Mn
Dec 29, 2024 -192.99 Mn
Sep 29, 2024 -873.74 Mn
Jun 30, 2024 -26.50 Mn
Mar 31, 2024 -35.01 Mn
Dec 31, 2023 -19.61 Mn
Oct 1, 2023 -586.05 Mn
Jul 2, 2023 -228.27 Mn
Apr 2, 2023 -113.19 Mn
Jan 1, 2023 -3.74 Bn
Apr 3, 2022 -164.86 Mn
Oct 3, 2021 2.76 Bn
Jul 4, 2021 -257.72 Mn
Apr 4, 2021 582.99 Mn
Jan 3, 2021 73.43 Mn